BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11485908)

  • 1. Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
    Hoon DS; Kuo CT; Wen S; Wang H; Metelitsa L; Reynolds CP; Seeger RC
    Am J Pathol; 2001 Aug; 159(2):493-500. PubMed ID: 11485908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of GD2 synthase mRNA by real-time reverse transcription-polymerase chain reaction: utility in bone marrow purging of neuroblastoma by anti-GD2 antibody 3F8.
    Cheung IY; Lo Piccolo MS; Collins N; Kushner BH; Cheung NK
    Cancer; 2002 Jun; 94(11):3042-8. PubMed ID: 12115395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.
    Pagani A; Macri L; Faulkner LB; Tintori V; Paoli A; Garaventa A; Bussolati G
    Diagn Mol Pathol; 2002 Jun; 11(2):98-106. PubMed ID: 12045713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
    Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GD2 synthase: a new molecular marker for detecting neuroblastoma.
    Lo Piccolo MS; Cheung NK; Cheung IY
    Cancer; 2001 Aug; 92(4):924-31. PubMed ID: 11550167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
    Kuo CT; Bostick PJ; Irie RF; Morton DL; Conrad AJ; Hoon DS
    Clin Cancer Res; 1998 Feb; 4(2):411-8. PubMed ID: 9516930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
    Cheung IY; Cheung NK
    Clin Cancer Res; 2001 Jun; 7(6):1698-705. PubMed ID: 11410509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
    Bilchik A; Miyashiro M; Kelley M; Kuo C; Fujiwara Y; Nakamori S; Monden M; Hoon DS
    Cancer; 2000 Mar; 88(5):1037-44. PubMed ID: 10699892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Horibe K; Fukuda M; Matsumoto K; Numata S; Mori H; Kato K
    Cancer; 1996 Mar; 77(6):1214-9. PubMed ID: 8635146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
    Negrin RS; Pesando J
    J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma.
    Cheung IY; Cheung NK
    Clin Cancer Res; 1997 May; 3(5):821-6. PubMed ID: 9815755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction.
    Mattano LA; Moss TJ; Emerson SG
    Cancer Res; 1992 Sep; 52(17):4701-5. PubMed ID: 1380888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
    Fukuda M; Miyajima Y; Miyashita Y; Horibe K
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
    Kuroda T; Saeki M; Nakano M; Mizutani S
    J Pediatr Surg; 1997 Jan; 32(1):69-72. PubMed ID: 9021573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
    Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
    J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of neuroblastoma cells in blood by reverse transcriptase-polymerase chain reaction.
    Gao Y; Li G; Zhang X; Xu Q; Zheng B
    Chin Med J (Engl); 1997 May; 110(5):341-5. PubMed ID: 9594298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.
    Shono K; Tajiri T; Fujii Y; Suita S
    J Pediatr Surg; 2000 Oct; 35(10):1415-20. PubMed ID: 11051140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines.
    Yamashiro S; Ruan S; Furukawa K; Tai T; Lloyd KO; Shiku H; Furukawa K
    Cancer Res; 1993 Nov; 53(22):5395-400. PubMed ID: 8221677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.